Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
"But at $700 a month, that's not going to happen." Even as weight loss drugs such as Wegovy and Zepbound explode in ...
A study of two popular weight loss drugs, Zepbound and Wegovy, found that Zepbound was more effective helping people lose ...
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says ...
MIT researchers have developed a type of gastric balloon that can be inflated and deflated in a person's stomach to mimic the ...
Speaking at The New York Times’s DealBook Summit, Eli Lilly’s chief executive and an obesity medicine specialist discussed ...
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...
A new study is out that compares the effectiveness of two popular weight loss drugs, Wegovy and Zepbound. The study, which ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Advertisements for a brand of chocolate touted as a weight loss product called Slymchoco continued to surface online despite ...